These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11127630

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Depot neuroleptic therapy: an underutilized treatment option.
    Glazer WM, Kane JM.
    J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
    [Abstract] [Full Text] [Related]

  • 23. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K, Rathbone J.
    Cochrane Database Syst Rev; 2006 Jan 25; (1):CD000459. PubMed ID: 16437425
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
    Sim K, Su A, Chan YH, Shinfuku N, Kua EH, Tan CH.
    Psychiatry Clin Neurosci; 2004 Jun 25; 58(3):324-9. PubMed ID: 15149301
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
    Minzenberg MJ, Poole JH, Benton C, Vinogradov S.
    Am J Psychiatry; 2004 Jan 25; 161(1):116-24. PubMed ID: 14702259
    [Abstract] [Full Text] [Related]

  • 29. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec 25; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ, Soares KV.
    Cochrane Database Syst Rev; 2000 Dec 25; (2):CD000459. PubMed ID: 10796546
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients.
    Janno S, Holi M, Tuisku K, Wahlbeck K.
    Am J Psychiatry; 2004 Jan 25; 161(1):160-3. PubMed ID: 14702266
    [Abstract] [Full Text] [Related]

  • 36. Neuroleptics in acute mania: a pharmacoepidemiologic study.
    Chou JC, Zito JM, Vitrai J, Craig TJ, Allingham BH, Czobor P.
    Ann Pharmacother; 1996 Dec 25; 30(12):1396-8. PubMed ID: 8968450
    [Abstract] [Full Text] [Related]

  • 37. An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels.
    Ng CH, Chong SA, Lambert T, Fan A, Hackett LP, Mahendran R, Subramaniam M, Schweitzer I.
    Int Clin Psychopharmacol; 2005 May 25; 20(3):163-8. PubMed ID: 15812267
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.